Download Medical Notes on EvaluatePharma pharmaceutical industry world review 2019 and outlook 2024

EvaluatePharma pharmaceutical industry world review 2019 and outlook 2024 Medical Notes

About This Presentation

Description:This is the twelfth edition of EvaluatePharma’s World Preview. The report brings together many of EvaluatePharma’s analyses to provide a top-level insight, from the world’s financial markets, into the expected performance of the pharmaceutical industry between now and 2024. This report is based on EvaluatePharma’s coverage of the leading global pharmaceutical and biotech companies. This report on pharma industry highlights trends in prescription drug sales, patent risk, R&D spend by pharma players, global brand sales and market performance by therapy area. This report also includes analyses on Worldwide Pharma Innovation with insights into risk and reward in the pharmaceutical industry.

Tags:EvaluatePharma, pharmaceutical industry, pharma, pharmaceutical, financial markets, R&D

Published on: Jun 29, 2020 | Views : 1221 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.3

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.3

Managed Care Career Path for Student Pharmacists

The Pharmaceutical Industry in Europe – Facts and Figure

Indian Biotechnology Industry Analysis by IBEF

EvaluatePharma Orphan Drug Report 2020

Understanding Medicine Spending in Australia - Trends and dynamics in healthcare and medicine spending

The financialisation of Big Pharma

COVID-19: Super-charging Drug Development in the Race for a Cure

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

Coronavirus COVID-19 response for Pharma companies

HEALTH A TO Z